OFFICIAL PUBLICATION OF

by its subsidiary APPco

PBS clarifies biosimilar warning codes

Nicholas O’Donoghue 08/12/2023

Warning codes not always a block on biosimilar substitution, Pharmaceutical Benefits Scheme (PBS) says Pharmacists receiving PBS warning reason codes 162 and 163 when substituting a biosimilar for a reference brand are being urged to ensure they have the correct item code of the dispensed product. In a statement issued by the Department of Health

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘We need more pharmacists’

Hmmm…how could we possibly get more pharmacists to go rural…hmmm….oh wait! What’s that thing called again? You know…it starts with…

John Smith

What does the future look like for CWH/Sigma shareholders?

But doesn’t this change as they slowly cripple their competition? It’s the classic Walmart move. Walk in, kill the competition…

John Smith

What does the future look like for CWH/Sigma shareholders?

I’m not sure if I’m just cynical but Ponraj came across as incredibly naive in this article. He was surprised…

John Smith

‘Doctor of Pharmacy’ title announced

Will any of this lead to direct claiming from Medicare for our new doctors?

John Smith

PBS clarifies biosimilar warning codes

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Ex netball chief scores Guild role

Next Whale swallows minnow; the Sigma CWH reverse takeover

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.